These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 23523844)

  • 1. Foxf2: a mesenchymal regulator of intestinal adenoma development.
    van den Brink GR; Rubin DC
    Gastroenterology; 2013 May; 144(5):873-6. PubMed ID: 23523844
    [No Abstract]   [Full Text] [Related]  

  • 2. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
    Nik AM; Reyahi A; Pontén F; Carlsson P
    Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-182 promotes cell growth and invasion by targeting forkhead box F2 transcription factor in colorectal cancer.
    Zhang Y; Wang X; Wang Z; Tang H; Fan H; Guo Q
    Oncol Rep; 2015 May; 33(5):2592-8. PubMed ID: 25738520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma.
    Jayson GC; Vives C; Paraskeva C; Schofield K; Coutts J; Fleetwood A; Gallagher JT
    Int J Cancer; 1999 Jul; 82(2):298-304. PubMed ID: 10389767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
    Lo PK; Lee JS; Liang X; Sukumar S
    Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration.
    Meyer-Schaller N; Heck C; Tiede S; Yilmaz M; Christofori G
    Breast Cancer Res; 2018 Oct; 20(1):118. PubMed ID: 30285803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
    Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
    Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantifying human intestinal stem cell and crypt dynamics: the implications for cancer screening and prevention.
    Baker AM; Graham TA
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):277-9. PubMed ID: 26690852
    [No Abstract]   [Full Text] [Related]  

  • 9. 32/67-kD laminin receptor expression in human colonic neoplasia: elevated transcript levels correlate with the degree of epithelial dysplasia.
    Stallmach A; Orzechowski HD; Feldmann P; Riecken EO; Zeitz M; Herbst H
    Am J Gastroenterol; 1999 Nov; 94(11):3341-7. PubMed ID: 10566741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tales from the human crypt--intestinal stem cell repertoire and the origins of human cancer.
    Playford RJ
    J Pathol; 1998 Jun; 185(2):119-22. PubMed ID: 9713336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 expression in colorectal cancer.
    Weg-Remers S; Schüder G; Zeitz M; Stallmach A
    Ann N Y Acad Sci; 1998 Nov; 859():304-6. PubMed ID: 9928409
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor.
    Kong PZ; Yang F; Li L; Li XQ; Feng YM
    PLoS One; 2013; 8(4):e61591. PubMed ID: 23620774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells.
    Tian HP; Lun SM; Huang HJ; He R; Kong PZ; Wang QS; Li XQ; Feng YM
    J Biol Chem; 2015 Jul; 290(31):19173-83. PubMed ID: 26070560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead box F2 regulation of platelet-derived growth factor and myocardin/serum response factor signaling is essential for intestinal development.
    Bolte C; Ren X; Tomley T; Ustiyan V; Pradhan A; Hoggatt A; Kalin TV; Herring BP; Kalinichenko VV
    J Biol Chem; 2015 Mar; 290(12):7563-75. PubMed ID: 25631042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2-IRF2BPL-β-Catenin Signaling Axis.
    Higashimori A; Dong Y; Zhang Y; Kang W; Nakatsu G; Ng SSM; Arakawa T; Sung JJY; Chan FKL; Yu J
    Cancer Res; 2018 Apr; 78(7):1643-1656. PubMed ID: 29374064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A non-radioactive method used for Reverse Northern].
    Zhang YW; Lai MD
    Yi Chuan; 2004 May; 26(3):353-5. PubMed ID: 15640018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.
    Kang LJ; Yu ZH; Cai J; He R; Lu JT; Hou C; Wang QS; Li XQ; Zhang R; Feng YM
    FASEB J; 2019 May; 33(5):6564-6573. PubMed ID: 30807702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients.
    Shi Z; Liu J; Yu X; Huang J; Shen S; Zhang Y; Han R; Ge N; Yang Y
    Ann Surg Oncol; 2016 Jan; 23(1):211-7. PubMed ID: 25824262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXF2 deficiency promotes hepatocellular carcinoma metastasis by inducing mesenchymal-epithelial transition.
    Dou C; Jin X; Sun L; Zhang B; Han M; Li T
    Cancer Biomark; 2017 Jul; 19(4):447-454. PubMed ID: 28582850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.